The multifaceted roles of activating transcription factor 3 (ATF3) in inflammatory responses – Potential target to regulate neuroinflammation in acute brain injury
暂无分享,去创建一个
Chen Chen | Yan Li | Peiying Li | Xin Wang | Wei Xuan | Weifeng Yu | Qi-chao Fan | Fengshi Li | Rui Pang
[1] Xi Yang,et al. ATF3 in atherosclerosis: a controversial transcription factor , 2022, Journal of Molecular Medicine.
[2] Hui-Chun Huang,et al. Predictive value of longitudinal changes of serum matrix metalloproteinase-9 and brain-derived neurotrophic factor in acute ischemic stroke , 2022, Frontiers in Aging Neuroscience.
[3] Lianwen Zhang,et al. Glucose Starvation Causes ptauS409 Increase in N2a Cells Through ATF3/PKAcα Signaling Pathway , 2022, Neurochemical Research.
[4] S. Lalwani,et al. Altered expression of activating transcription factor 3 in the hippocampus of patients with mesial temporal lobe epilepsy-hippocampal sclerosis (MTLE-HS) , 2022, The International journal of neuroscience.
[5] Jianyun Yan,et al. A novel function of ATF3 in suppression of ferroptosis in mouse heart suffered ischemia/reperfusion. , 2022, Free radical biology & medicine.
[6] T. G. Singh,et al. Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches. , 2022, International immunopharmacology.
[7] Yangfan Wang,et al. Phagocytic microglia and macrophages in brain injury and repair , 2022, CNS neuroscience & therapeutics.
[8] Hao Wang,et al. Transplantation of Roxadustat‐preconditioned bone marrow stromal cells improves neurological function recovery through enhancing grafted cell survival in ischemic stroke rats , 2022, CNS neuroscience & therapeutics.
[9] A. Dzutsev,et al. Microbiota and adipocyte mitochondrial damage in type 2 diabetes are linked by Mmp12+ macrophages , 2022, The Journal of experimental medicine.
[10] Xiuli Yi,et al. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis , 2022, Journal for ImmunoTherapy of Cancer.
[11] Jeonghyun Choi,et al. Pre‐ and post‐conditioning with poly I:C exerts neuroprotective effect against cerebral ischemia injury in animal models: A systematic review and meta‐analysis , 2022, CNS neuroscience & therapeutics.
[12] J. Björkegren,et al. Atherosclerosis: Recent developments , 2022, Cell.
[13] Chan Chen,et al. Transcriptome Profiles of IncRNA and mRNA Highlight the Role of Ferroptosis in Chronic Neuropathic Pain With Memory Impairment , 2022, Frontiers in Cell and Developmental Biology.
[14] Shixin Xu,et al. Microglia: The Hub of Intercellular Communication in Ischemic Stroke , 2022, Frontiers in Cellular Neuroscience.
[15] Jinfang Liu,et al. TFCP2, a binding protein of ATF3, promotes the progression of glioma by activating the synthesis of serine. , 2022, Experimental cell research.
[16] Xuehai Wu,et al. Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not , 2022, Frontiers in Immunology.
[17] Dakang Xu,et al. ATF3 Positively Regulates Antibacterial Immunity by Modulating Macrophage Killing and Migration Functions , 2022, Frontiers in Immunology.
[18] Xiuxin Fu,et al. Protective role of activating transcription factor 3 against neuronal damage in rats with cerebral ischemia , 2022, Brain and behavior.
[19] P. Adlard,et al. Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury , 2022, British journal of pharmacology.
[20] N. Na,et al. Identification of Subtypes and a Delayed Graft Function Predictive Signature Based on Ferroptosis in Renal Ischemia-Reperfusion Injury , 2022, Frontiers in Cell and Developmental Biology.
[21] A. Pandit,et al. Role and therapeutic implications of protein glycosylation in neuroinflammation. , 2022, Trends in molecular medicine.
[22] D. Geschwind,et al. Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells , 2022, Neuron.
[23] E. Krüger,et al. Proteasome dysfunction disrupts adipogenesis and induces inflammation via ATF3 , 2022, bioRxiv.
[24] Yang Liu,et al. Neuroinflammation in perioperative neurocognitive disorders: From bench to the bedside , 2022, CNS neuroscience & therapeutics.
[25] Cheng Li,et al. BMPER alleviates ischemic brain injury by protecting neurons and inhibiting neuroinflammation via Smad3‐Akt‐Nrf2 pathway , 2021, CNS neuroscience & therapeutics.
[26] Jun Liu,et al. Identification and Validation of ATF3 Serving as a Potential Biomarker and Correlating With Pharmacotherapy Response and Immune Infiltration Characteristics in Rheumatoid Arthritis , 2021, Frontiers in Molecular Biosciences.
[27] Yuwei Zhou,et al. Substrate Viscoelasticity Amplifies Distinctions between Transient and Persistent LPS‐Induced Signals , 2021, Advanced healthcare materials.
[28] R. Turner,et al. Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke? , 2021, International journal of molecular sciences.
[29] Yawei Liu,et al. Transcriptomic Analysis Reveals that Activating Transcription Factor 3/c-Jun/Lgals3 Axis Is Associated with Central Diabetes Insipidus after Hypothalamic Injury , 2021, Neuroendocrinology.
[30] V. Risbrough,et al. Role of Inflammation in Traumatic Brain Injury–Associated Risk for Neuropsychiatric Disorders: State of the Evidence and Where Do We Go From Here , 2021, Biological Psychiatry.
[31] K. Lu,et al. Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma. , 2021, Cancer letters.
[32] D. McGavern,et al. Antimicrobial immunity impedes CNS vascular repair following brain injury , 2021, Nature Immunology.
[33] C. Adams,et al. Exercise-induced angiogenesis is dependent on metabolically primed ATF3/4+ endothelial cells , 2021, Cell metabolism.
[34] S. Guglietta,et al. Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study , 2021, Acta Neuropathologica Communications.
[35] X. Ji,et al. Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases , 2021, CNS neuroscience & therapeutics.
[36] Wenling Zhang,et al. Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy , 2021, Genes & diseases.
[37] C. Keene,et al. Traumatic Brain Injury and Risk of Neurodegenerative Disorder , 2021, Biological Psychiatry.
[38] Alyssa R. Richman,et al. p38 MAP Kinase Signaling in Microglia Plays a Sex-Specific Protective Role in CNS Autoimmunity and Regulates Microglial Transcriptional States , 2021, Frontiers in Immunology.
[39] T. Eleftheriadis,et al. Role of indoleamine 2,3-dioxygenase in ischemia-reperfusion injury of renal tubular epithelial cells , 2021, Molecular medicine reports.
[40] Xu Zhang,et al. Single-cell transcriptomic analysis of somatosensory neurons uncovers temporal development of neuropathic pain , 2021, Cell Research.
[41] R. Leak,et al. Microglial/Macrophage polarization and function in brain injury and repair after stroke , 2021, CNS neuroscience & therapeutics.
[42] J. C. Love,et al. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage , 2021, Science Immunology.
[43] Jian Zhou,et al. ATF3: a novel biomarker for the diagnosis of acute kidney injury after cardiac surgery , 2021, Annals of translational medicine.
[44] N. Tyagi,et al. Effects of fibrinogen synthesis inhibition on vascular cognitive impairment during traumatic brain injury in mice , 2020, Brain Research.
[45] D. Vivien,et al. Filling the gaps on stroke research: Focus on inflammation and immunity , 2020, Brain, Behavior, and Immunity.
[46] D. Belsham,et al. Bisphenol A Induces Agrp Gene Expression in Hypothalamic Neurons through a Mechanism Involving ATF3 , 2020, Neuroendocrinology.
[47] M. Wintermark,et al. Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source. , 2020, European heart journal.
[48] Johan Bo Davidsson,et al. Diffuse Axonal Injury in the Rat Brain: Axonal Injury and Oligodendrocyte Activity Following Rotational Injury , 2020, Brain sciences.
[49] M. Hung,et al. ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis. , 2020, Cancer cell.
[50] D. Geschwind,et al. Transcriptional Reprogramming of Distinct Peripheral Sensory Neuron Subtypes after Axonal Injury , 2019, Neuron.
[51] J. Rutledge,et al. Mitochondrial oxidative stress-induced transcript variants of ATF3 mediate lipotoxic brain microvascular injury. , 2019, Free radical biology & medicine.
[52] G. Stoll,et al. Thrombo-inflammation in acute ischaemic stroke — implications for treatment , 2019, Nature Reviews Neurology.
[53] N. Selvamurugan,et al. Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions. , 2018, International journal of biological macromolecules.
[54] Jian-ru Li,et al. Fluoxetine attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage: a possible role for the regulation of TLR4/MyD88/NF-κB signaling pathway , 2018, Journal of Neuroinflammation.
[55] Xin Wang,et al. The peripheral immune response after stroke—A double edge sword for blood‐brain barrier integrity , 2018, CNS neuroscience & therapeutics.
[56] A. Ignatius,et al. Neuroinflammation after Traumatic Brain Injury Is Enhanced in Activating Transcription Factor 3 Mutant Mice. , 2018, Journal of Neurotrauma.
[57] Q. Tang,et al. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target , 2018, Basic Research in Cardiology.
[58] J. Ryu,et al. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics , 2018, Nature Reviews Neuroscience.
[59] Maxim N. Artyomov,et al. Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis , 2018, Nature.
[60] Yanqiao Zhang,et al. Activating transcription factor 3 in immune response and metabolic regulation. , 2017, Liver research.
[61] D. Menon,et al. Monitoring the Neuroinflammatory Response Following Acute Brain Injury , 2017, Front. Neurol..
[62] P. Reaven,et al. HDL inhibits saturated fatty acid mediated augmentation of innate immune responses in endothelial cells by a novel pathway. , 2017, Atherosclerosis.
[63] Hülya Bayır,et al. The far-reaching scope of neuroinflammation after traumatic brain injury , 2017, Nature Reviews Neurology.
[64] James J. McCarthy,et al. Cortical Thickness in Mild Traumatic Brain Injury. , 2016, Journal of neurotrauma.
[65] D. McGavern,et al. Inflammatory neuroprotection following traumatic brain injury , 2016, Science.
[66] E. Hinoi,et al. Protective upregulation of activating transcription factor‐3 against glutamate neurotoxicity in neuronal cells under ischemia , 2016, Journal of neuroscience research.
[67] P. Bergold. Treatment of traumatic brain injury with anti-inflammatory drugs , 2016, Experimental Neurology.
[68] Shruti V. Kabadi,et al. Repeated Mild Traumatic Brain Injury Causes Chronic Neuroinflammation, Changes in Hippocampal Synaptic Plasticity, and Associated Cognitive Deficits , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[69] H. Feng,et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury , 2014, Journal of Neuroinflammation.
[70] Melissa D. Laird,et al. High mobility group box protein‐1 promotes cerebral edema after traumatic brain injury via activation of toll‐like receptor 4 , 2014, Glia.
[71] E. Latz,et al. High density lipoprotein mediates anti-inflammatory transcriptional reprogramming of macrophages via the transcriptional repressor ATF3 , 2013, Nature Immunology.
[72] B. Prakken,et al. Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgery , 2013, Journal of Neuroinflammation.
[73] D. Loane,et al. Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention , 2012, Brain, Behavior, and Immunity.
[74] L. Wang,et al. Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice , 2012, Neuroscience.
[75] R. Morita,et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain , 2012, Nature Medicine.
[76] R. Moritz,et al. ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol–induced lipid body formation , 2012, The Journal of experimental medicine.
[77] Tsonwin Hai,et al. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression , 2011, Nature Medicine.
[78] S. Jung,et al. Role of activating transcription factor 3 in ischemic penumbra region following transient middle cerebral artery occlusion and reperfusion injury , 2011, Neuroscience Research.
[79] D. Janigro,et al. A Dynamic in vitro BBB Model for the Study of Immune Cell Trafficking into the Central Nervous System , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] S. Akira,et al. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia , 2010, Neuroscience.
[81] Guohong Li,et al. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells , 2010, Journal of leukocyte biology.
[82] David L. Thomas,et al. Overexpression of Heat Shock Protein 27 Reduces Cortical Damage after Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[83] Matthew R. Thompson,et al. ATF3 transcription factor and its emerging roles in immunity and cancer , 2009, Journal of Molecular Medicine.
[84] Tsonwin Hai,et al. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. , 2007, Molecular immunology.
[85] Kathleen A. Kennedy,et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4 , 2006, Nature.
[86] J. Younger,et al. The Role of Complement C3 in Intracerebral Hemorrhage-Induced Brain Injury , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[87] B. Stoica,et al. Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. , 2003, Journal of neurotrauma.
[88] M. Isobe,et al. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. , 2002, Journal of molecular and cellular cardiology.
[89] OUP accepted manuscript , 2022, European Heart Journal.
[90] R. Leak,et al. Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.